1-22637683-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015991.4(C1QA):c.67G>A(p.Glu23Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00321 in 1,614,002 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E23Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_015991.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QA | NM_015991.4 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | ENST00000374642.8 | |
C1QA | NM_001347465.2 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | ||
C1QA | NM_001347466.2 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QA | ENST00000374642.8 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | 1 | NM_015991.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00320 AC: 487AN: 152146Hom.: 5 Cov.: 33
GnomAD3 exomes AF: 0.00316 AC: 794AN: 250948Hom.: 7 AF XY: 0.00313 AC XY: 425AN XY: 135676
GnomAD4 exome AF: 0.00321 AC: 4690AN: 1461738Hom.: 20 Cov.: 32 AF XY: 0.00317 AC XY: 2305AN XY: 727158
GnomAD4 genome AF: 0.00320 AC: 487AN: 152264Hom.: 5 Cov.: 33 AF XY: 0.00364 AC XY: 271AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | C1QA: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
C1Q deficiency Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Jul 25, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Oct 09, 2014 | - - |
C1QA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at